Page last updated: 2024-09-02

carboxyamido-triazole and Ischemia

carboxyamido-triazole has been researched along with Ischemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Franklin, AJ; Jetton, TL; Kohn, EC; Kuchemann, CL; Russell, SR	1

Other Studies

1 other study(ies) available for carboxyamido-triazole and Ischemia

Article	Year
CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy. Investigative ophthalmology & visual science, 2004, Volume: 45, Issue:10 Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Antineoplastic Agents; Disease Models, Animal; Fluorescein Angiography; Hyperoxia; In Situ Nick-End Labeling; Ischemia; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Retinal Neovascularization; Retinal Vessels; Triazoles	2004

Article

Year

CAI is a potent inhibitor of neovascularization and imparts neuroprotection in a mouse model of ischemic retinopathy.

Investigative ophthalmology & visual science, 2004, Volume: 45, Issue:10

Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Antineoplastic Agents; Disease Models, Animal; Fluorescein Angiography; Hyperoxia; In Situ Nick-End Labeling; Ischemia; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Retinal Neovascularization; Retinal Vessels; Triazoles

2004